{{Rsnum
|rsid=11225297
|Chromosome=11
|position=102517147
|Orientation=plus
|GMAF=0.1129
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 77.0 | 22.1 | 0.9
| HCB | 64.7 | 30.9 | 4.4
| JPT | 69.9 | 27.4 | 2.7
| YRI | 99.3 | 0.7 | 0.0
| ASW | 98.2 | 1.8 | 0.0
| CHB | 64.7 | 30.9 | 4.4
| CHD | 59.6 | 36.7 | 3.7
| GIH | 86.9 | 12.1 | 1.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 65.5 | 31.0 | 3.4
| MKK | 96.1 | 3.9 | 0.0
| TSI | 77.5 | 21.6 | 1.0
| HapMapRevision=28
}}
{{PMID|18798254|OA=1
}} Chinese [[breast cancer]] [[rs11225297]](T) improved survival. (A;T) (OS HR: 0.7, 95% CI: 0.5-0.9) and (T;T) (OS HR: 0.3, 95% CI: 0.1-0.8)

{{PMID Auto
|PMID=18648013
|Title=Common MMP-7 polymorphisms and breast cancer susceptibility: a multistage study of association and functionality.
|OA=1
}}

{{PMID Auto
|PMID=19435861
|Title=No association between matrix metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and endometrial cancer risk.
|OA=1
}}

{{PMID Auto
|PMID=22367361
|Title=Replication study for reported SNP associations with breast cancer survival.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}